Menu
Search
Home > Courses > Best of ACTHIV: Cardiovascular Risk Management in HIV

Best of ACTHIV: Cardiovascular Risk Management in HIV

Best of ACTHIV: Cardiovascular Risk Management in HIV
Play
Sorry, this learning module is not available for mobile devices.
ACTHIV
Original Release Date: 9/15/2019
Review Date: 9/15/2019
Presenter
  • Judith A. Berg, MD
    George Baehr Professor of Medicine
    Icahn School of Medicine at Mount Sinai Health System
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Educate and counsel persons with HIV on risk factor modification to reduce the risk of cardiovascular disease.
  2. Detect and manage cardiovascular risk factors among persons with HIV according to evidence-based guidelines.
Presenter Bio
Judith Berg, MD
A nationally renowned researcher in the field of HIV and AIDS, Dr. Aberg has been instrumental in developing national, state, and local guidelines for HIV prevention and the care of HIV-infected persons. Her reputation as a scientific leader has been well established through her ongoing clinical research activities in HIV-related opportunistic infections, vaccine response, and complications of HIV disease, including studies of the pathogenesis of inflammation that contributes to the co-morbidities associated with the aging of those with HIV infection. Dr. Aberg serves as Chief of the Division of Infectious Diseases and Immunology and Director of the Infectious Diseases Clinical and Translational Research Center. Dr. Aberg serves on panels for the New York State Department of Health, the International AIDS Society-USA, and the Department of Health and Human Services. She was also Chair of the HIV Medicine Association (HIVMA), an organization representing more than 5,000 HIV providers advocating for policies to ensure a comprehensive response to the AIDS pandemic informed by science and social justice. She was recently elected as the HIVMA representative to the Infectious Disease Society of America’s Board of Directors. Dr. Aberg is the author of more than 100 peer-reviewed publications and has participated in more than 100 clinical trials. She is Co-Editor-in-Chief for HIV Clinical Trials, serves on the editorial board for two infectious disease journals, and is an ad hoc reviewer for more than 15 journals.
Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

The enduring material is jointly provided by Beaumont Health, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).

The 13th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 11-13, 2019 in Miami, FL. The Conference was supported by the Clinical Education Initiative, New York State Department of Health, AIDS Institute. The conference and this web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., and ViiV HealthCare.

Hardware/Software Requirements To access this activity hardware and software requirements are noted below.

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later

Copyright 2019. American Academy of CME, Inc., Beaumont Health, and American Conference for the Treatment of HIV.

Resources: